$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
奥拉帕尼治疗卵巢癌的安全性如何?
2025-10-19 11:44:20
Check Details
尼拉帕尼在高级别浆液性卵巢癌中的抗肿瘤活性
2025-10-19 11:44:20
Check Details
尼拉帕尼延长复发性卵巢癌无进展生存期
2025-10-19 11:44:20
Check Details
复发性卵巢癌治疗重大突破:尼拉帕尼延长铂类敏感型癌症的无进展生存期
2025-10-19 11:44:20
Check Details
奥拉帕尼上市,国内卵巢癌患者的福音
2025-10-19 11:44:20
Check Details
尼拉帕尼治疗复发性卵巢癌的长期获益
2025-10-19 11:44:20
Check Details
尼拉帕尼治疗复发性卵巢癌患者
2025-10-19 11:44:20
Check Details
奥拉帕尼常见的不良反应
2025-10-19 11:44:20
Check Details
尼拉帕尼显著改善卵巢癌患者生存期
2025-10-19 11:44:20
Check Details
卡博替尼适应症之卵巢癌
2025-10-19 11:44:20
Check Details
多吉美抗肿瘤治疗之卵巢癌
2025-10-19 11:44:20
Check Details
奥拉帕尼获批的适应症
2025-10-19 11:44:20
Check Details
1
2
...
759
760
761
762
763
764
765
...
4151
4152
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Fulvestrant (Faslodex) Breast Cancer Guide: Indications, Dosage and Safety Specifications
2
Adagrasib (Krazati): Full Guide to KRAS G12C Inhibitor for Cancer Treatment
3
Comprehensive Analysis of the Third-Generation EGFR-TKI
4
ATOMIC Study: Atezolizumab Plus Chemo Improves DFS in dMMR Stage III Colon Cancer
5
Oncology Immunotherapy vs Anti-Inflammatory Biologic: Dostarlimab vs Secukinumab - A Mechanism-Centered Comparison
6
Third-Generation TKI Redefining Treatment for ALK+ & ROS1+ NSCLC
7
Brigatinib Medication Case Study: Three-Year Treatment Record and Experience Sharing of ALK-Positive Lung Cancer Patient
8
What is Brigatinib (Alunbrig)? Complete Guide to ALK-Positive Lung Cancer Targeted Therapy & Medication Guidelines
9
Repotrectinib (Augtyro) Complete Medication Guide 2026: Import Original Drug Price, Eligible Patients & Full Usage Information
10
Ceritinib Capsule Storage Conditions & Expiration Guide: Room Temperature Storage, No Refrigeration Needed
11
Selumetinib for NF1 Treatment: Complete Guide to Targeted Therapy for Type 1 Neurofibromatosis
12
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook